[go: up one dir, main page]

MX2016002104A - Vacuna para adenovirus aviar. - Google Patents

Vacuna para adenovirus aviar.

Info

Publication number
MX2016002104A
MX2016002104A MX2016002104A MX2016002104A MX2016002104A MX 2016002104 A MX2016002104 A MX 2016002104A MX 2016002104 A MX2016002104 A MX 2016002104A MX 2016002104 A MX2016002104 A MX 2016002104A MX 2016002104 A MX2016002104 A MX 2016002104A
Authority
MX
Mexico
Prior art keywords
fadv
fowl adenovirus
protein
fiber
adenovirus vaccine
Prior art date
Application number
MX2016002104A
Other languages
English (en)
Other versions
MX371174B (es
Inventor
Hess Michael
Schachner Anna
MAREK Ana
Jaskulska Barbara
Original Assignee
Veterinärmedizinische Universität Wien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48985680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2016002104(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Veterinärmedizinische Universität Wien filed Critical Veterinärmedizinische Universität Wien
Publication of MX2016002104A publication Critical patent/MX2016002104A/es
Publication of MX371174B publication Critical patent/MX371174B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10211—Aviadenovirus, e.g. fowl adenovirus A
    • C12N2710/10234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10211—Aviadenovirus, e.g. fowl adenovirus A
    • C12N2710/10271—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se describe una vacuna que comprende proteína de fibra, seleccionada de proteína de fibra 2 de Adenovirus C Aviar (FAdV-C), Adenovirus A Aviar de proteína de fibra 2 (FAdV-A), proteína de fibra de Adenovirus Aviar B, D y E (FAdV-B, FAdV-D y FAdV-E), o un fragmento inmunogénico de los mismos para usar en la prevención del Síndrome de HepatitisHidropericardio (SHH) o hepatitis por cuerpos de inclusión (IBH) o Erosión de Molleja o Gizzard (GE), en aves, preferiblemente en aves de corral, especialmente en pollos de engorda.
MX2016002104A 2013-08-19 2014-08-19 Vacuna para adenovirus aviar. MX371174B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13180860.2A EP2839841A1 (en) 2013-08-19 2013-08-19 Fowl adenovirus vaccine
PCT/EP2014/067647 WO2015024929A2 (en) 2013-08-19 2014-08-19 Fowl adenovirus vaccine

Publications (2)

Publication Number Publication Date
MX2016002104A true MX2016002104A (es) 2016-11-11
MX371174B MX371174B (es) 2020-01-20

Family

ID=48985680

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016002104A MX371174B (es) 2013-08-19 2014-08-19 Vacuna para adenovirus aviar.

Country Status (10)

Country Link
US (1) US10220088B2 (es)
EP (2) EP2839841A1 (es)
JP (1) JP6577470B2 (es)
AU (1) AU2014310676B2 (es)
BR (1) BR112016003338B1 (es)
CA (1) CA2921394C (es)
CL (2) CL2016000358A1 (es)
ES (1) ES2896483T3 (es)
MX (1) MX371174B (es)
WO (1) WO2015024929A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2839841A1 (en) 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine
EP2839838A1 (en) * 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine
CN109134646A (zh) * 2017-06-28 2019-01-04 哈药集团生物疫苗有限公司 Ⅰ群血清4型禽腺病毒卵黄抗体的制备方法及其制品
CN110579607A (zh) * 2018-06-08 2019-12-17 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 一种fadv a病毒间接elisa抗体检测试剂盒及其应用
CN108918869B (zh) * 2018-06-15 2021-12-28 新兴县国研科技有限公司 fiber2蛋白及其重组蛋白在检测血清4型禽腺病毒抗体方面的应用
CN109721642B (zh) * 2018-12-26 2021-08-24 乾元浩生物股份有限公司 一种i群血清4型-血清8型禽腺病毒二价亚单位疫苗及其制备方法
CN110616278B (zh) * 2019-08-09 2022-08-12 山东省农业科学院家禽研究所 检测fav-8和fav-11的特异性引物及试剂盒
CN111269892B (zh) * 2020-03-06 2023-07-11 哈尔滨科欣农业科技有限公司 I群4型禽腺病毒dn株、禽腺病毒灭活疫苗及其制备方法和应用
JP7648071B2 (ja) * 2020-05-18 2025-03-18 株式会社コンピュータシステム研究所 監視装置、監視プログラム、記憶媒体、および、監視方法
CN112048570A (zh) * 2020-08-12 2020-12-08 广东省农业科学院动物卫生研究所 一种检测鸭腺病毒4型的pcr引物及其检测方法与应用
CN112626279A (zh) * 2021-01-21 2021-04-09 福建省农业科学院畜牧兽医研究所 检测新发鸭4型腺病毒的实时荧光定量pcr引物及试剂盒
CN112852760A (zh) * 2021-03-04 2021-05-28 温氏食品集团股份有限公司 重组鸭肠炎病毒及其应用
CN113198011B (zh) * 2021-04-28 2023-05-09 重庆永健生物技术有限责任公司 一种鸭腺病毒3型菌株灭活疫苗及其应用
KR102656435B1 (ko) * 2021-12-13 2024-04-11 주식회사 중앙백신연구소 신규한 가금 아데노바이러스 및 이를 유효성분으로 포함하는 가금 아데노바이러스 다가백신
EP4205759A1 (en) 2022-01-04 2023-07-05 Veterinärmedizinische Universität Wien Fowl adenovirus subunit vaccine and production method thereof
CN114703153B (zh) * 2022-06-06 2022-08-02 广东省农业科学院动物卫生研究所 一株血清2型禽腺病毒毒株以及疫苗和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615803A1 (de) 1996-04-20 1997-10-23 Boehringer Ingelheim Int CELO-Virus
WO2003039593A1 (en) 2001-11-08 2003-05-15 Akzo Nobel N.V. Fowl adenovirus vaccine
AU2003209648A1 (en) * 2003-03-04 2004-09-28 Abic Ltd. Subunits of the adenovirus fiber protein and uses thereof as vaccines
US8080642B2 (en) * 2003-05-16 2011-12-20 Vical Incorporated Severe acute respiratory syndrome DNA compositions and methods of use
CA2725435C (en) * 2009-12-15 2023-01-03 University Of Saskatchewan Vaccines for inclusion body hepatitis
EP2839838A1 (en) * 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine
EP2839841A1 (en) * 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine

Also Published As

Publication number Publication date
JP2016528270A (ja) 2016-09-15
EP3035963B1 (en) 2021-10-20
US20160199484A1 (en) 2016-07-14
ES2896483T3 (es) 2022-02-24
BR112016003338A2 (pt) 2017-11-21
AU2014310676A2 (en) 2016-05-12
JP6577470B2 (ja) 2019-09-18
CA2921394A1 (en) 2015-02-26
MX371174B (es) 2020-01-20
CL2016000358A1 (es) 2016-09-09
CL2018001159A1 (es) 2018-06-22
CA2921394C (en) 2023-09-05
EP2839841A1 (en) 2015-02-25
WO2015024929A2 (en) 2015-02-26
EP3035963A2 (en) 2016-06-29
AU2014310676A1 (en) 2016-03-03
BR112016003338B1 (pt) 2023-03-07
AU2014310676B2 (en) 2019-09-12
US10220088B2 (en) 2019-03-05
WO2015024929A3 (en) 2015-05-07

Similar Documents

Publication Publication Date Title
MX2016002104A (es) Vacuna para adenovirus aviar.
MX2016002160A (es) Vacuna para adenovirus aviar.
CY1123563T1 (el) Ανοσογονικα wt-1 πεπτιδια και μεθοδοι χρησης αυτων
PH12015502790A1 (en) Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
PH12018501602A1 (en) Subunit immersion vaccines for fish
HUS2300022I1 (hu) Készítmények és eljárások vakcinák dengue vírus kiméra-konstrukcióihoz
MX373792B (es) Coronavirus.
EP3162215A4 (en) Chicken carcass contour measurement device, contour measurement method, and chicken carcass deboning device
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
EP3012322A4 (en) GENEELED STRAIN VARIANT OF PORCINE PSEUDORABIES VIRUS, VACCINE COMPOSITION, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF
MX2015012737A (es) Vacunas de virus bovino liquidas estables.
BR112018012642A2 (pt) vacina de calicivírus felino
PH12013500222A1 (en) Compositions and methods for treating hepatitis virus infection
PH12018501154A1 (en) Attenuated infectious bronchitis virus
PH12018501750A1 (en) Porcine reproductive and respiratory syndrome vaccine virus
PL3772969T4 (pl) Urządzenie, sposób i układ do oddzielania końcówek skrzydeł od tuszek drobiowych
PH12013500156A1 (en) Modified infectious laryngotracheitis virus (iltv) and uses thereof
WO2014022788A3 (en) Chicken astrovirus responsible for runting stunting syndrome
IL290502A (en) Silicone substitute natural additive composition, process for obtaining the same and its use
EP3826672A4 (en) VACCINE AGAINST THE ZIKA VIRUS
TH1601001881A (th) โปรตีนทำงาน (functional protein) ซึ่งอนุพัทธ์จากเนื้อเยื้อกล้ามเนื้อสัตว์ หรือ เนื้อถอดกระดูกด้วยวิธีเชิงกล และวิธีการสำหรับการทำสิ่งเดียวกันนั้น
TH148817B (th) รีคอมบิแนนท์ไวรัสเริมของนกชนิดมัลติวาเลนต์ และวัคซีนเพื่อสร้างภูมิคุ้มกันสำหรับสปีชีส์ของนก
UA101499U (ru) Способ лечения экспериментального аллергического энцефаломиелита мезенхимальными стволовыми клетками (мск)
IL238354A0 (en) Recombinant vector assembly on the Newcastle disease virus differentiates between vaccinated and infected for use in humans, animals and/or poultry
UA60016U (ru) Способ повышения иммунного ответа при вакцинации птицы

Legal Events

Date Code Title Description
FG Grant or registration